Date | Subject |
---|---|
2022-12-19 21:34:24 | Good morning! #premarket #watchlist 12/20 $ICCM -IceCure's ProSense Safe and Effective in Treating Kidney Tumors with 89.5% Recurrence-Free Rate(+200%), $XCUR -13D form. big buys(+50%), $VRNA -Announces Ensifentrine Meets Primary and Key Secondary Endpoints in Phase 3 ENHANCE-1 Trial(+38%) |